With the introduction of adaptive deep brain stimulation (aDBS) for Parkinson's disease, new questions emerge regarding who, why, and how to treat. This paper outlines the pathophysiological rationale ...

Patients with CLL with mutated IGHV genes (M-CLL) have better outcomes than patients with unmutated IGHVs (U-CLL). Since U-CLL usually express immunoglobulins (IGs) that are more autoreactive and more ...

CD200, a transmembrane type Ia glycoprotein belonging to the immunoglobulin protein superfamily, is broadly expressed on a wide variety of cell types, such as B lymphocytes, a subset of T lymphocytes, ...

The workflow encompasses patient datacollection and screening, univariate regression analysis for initial variable selection, systematic comparison of 91 machine learning models,selection and ...

Roche, in collaboration with KlinRisk, Inc, has received CE-mark for the first AI-based risk stratification tool for assessment of progressive decline in kidney function. This tool will be launched as ...

"CAR T-Cell Therapy for Acute Lymphoblastic Leukemia Pipeline"DelveInsight's,“CAR T-Cell Therapy for Acute Lymphoblastic Leukemia - Pipeline Insight, 2025,” report provides comprehensive insights ...

Chronic lymphocytic leukemia (CLL) is the most common leukemia in adult patients living in the western hemisphere. The annual incidence of CLL is 4.2/100 000 people, with median (interquartile range ...

Whether fixed-duration acalabrutinib–venetoclax (with or without obinutuzumab) would result in better progression-free survival than chemoimmunotherapy in patients with untreated chronic lymphocytic ...

A risk stratification algorithm may be able to predict which patients with advanced chronic liver disease are at risk of developing hepatocellular carcinoma (HCC), according to a large-scale ...

David is comprehensively experienced in many facets of financial and legal research and publishing. As an Investopedia fact checker since 2020, he has validated over 1,100 articles on a wide range of ...